COSMO Pharmaceuticals SA (0RGI) — Capital Reinvestment Ratio
COSMO Pharmaceuticals SA (0RGI) has a Capital Reinvestment Ratio of 2.92x as of June 2025, meaning it reinvests 3% of its operating cash flow (£900.00K) in capital expenditures (£2.62 Million). See 0RGI equity to assets ratio to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
COSMO Pharmaceuticals SA Capital Reinvestment Ratio (2004–2024)
This chart tracks COSMO Pharmaceuticals SA's Capital Reinvestment Ratio across 15 annual periods. Check 0RGI total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for COSMO Pharmaceuticals SA (2004–2024)
Year-by-year Capital Reinvestment Ratio for COSMO Pharmaceuticals SA from 2004 to 2024. For live market cap and broader valuation context, see 0RGI company net worth.
| Year | Reinvestment Ratio | Operating CF (GBP) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.03x | £162.41 Million | £5.65 Million | ▼ -82.0% |
| 2023 | 0.19x | £22.71 Million | £4.40 Million | ▲ +42.4% |
| 2022 | 0.14x | £32.89 Million | £4.47 Million | ▼ -79.8% |
| 2021 | 0.67x | £12.61 Million | £8.50 Million | ▲ +8.3% |
| 2020 | 0.62x | £12.98 Million | £8.09 Million | ▼ -10.8% |
| 2016 | 0.70x | £26.41 Million | £18.43 Million | ▲ +1747.0% |
| 2014 | 0.04x | £66.45 Million | £2.51 Million | ▼ -88.8% |
| 2013 | 0.34x | £8.11 Million | £2.73 Million | ▲ +154.8% |
| 2012 | 0.13x | £23.00 Million | £3.04 Million | ▼ -55.8% |
| 2011 | 0.30x | £11.29 Million | £3.37 Million | ▼ -68.7% |
| 2010 | 0.95x | £7.79 Million | £7.42 Million | ▼ -45.0% |
| 2009 | 1.73x | £3.88 Million | £6.72 Million | ▲ +30.1% |
| 2006 | 1.33x | £6.08 Million | £8.10 Million | ▼ -46.1% |
| 2005 | 2.47x | £1.70 Million | £4.20 Million | ▼ -73.6% |
| 2004 | 9.36x | £261.00K | £2.44 Million | — |